Pharmacological, conformational and dynamic properties of cycloleucine‐2 analogues of oxytocin and [1‐penicillamine]oxytocin
- 12 January 1983
- journal article
- research article
- Published by Wiley in International Journal of Peptide and Protein Research
- Vol. 21 (1) , 24-34
- https://doi.org/10.1111/j.1399-3011.1983.tb03074.x
Abstract
The solid phase syntheses of [2‐cycloleucine]oxytocin and [1‐penicillamine, 2‐cycloleucine]oxytocin are reported. [1‐Penicillamine, 2‐cycloleucine]oxytocin is an oxytocin antagonist exhibiting no in vitro oxytocic activity. In the in vitro oxytocic assay, [1‐penicillamine, 2‐cycloleucine]oxytocin has a pA2 value of 6.70 ± 0.08. [2‐Cycloleucine]‐oxytocin is a full oxytocin agonist exhibiting 4.9 ± 0.5 U/mg of oxytocic activity. Neither compound possesses any measurable agonist or antagonist activity in the rat pressor assay. Carbon‐13 nuclear magnetic resonance chemical shift parameters and spin‐lattice relaxation times (T1) of the antagonist, [1‐penicillamine, 2‐cycloleucine]oxytocin, indicate that the antagonist exhibits similar conformational and dynamic properties as other oxytocin inhibitors previously studied. The carbon‐13 nuclear magnetic resonance shift parameters and spin‐lattice relaxation times (T1) of the oxytocin agonist, [2‐cycloleucine] oxytocin, indicate that the agonist exhibits similar conformational and dynamic properties as oxytocin. These results are discussed in terms of the different receptor requirements for agonist and antagonist activities. It appears that there are different structural and conformational requirements at the 2‐position for oxytocic agonist and antagonist activities.Keywords
This publication has 24 references indexed in Scilit:
- Conformational study of the potent peptide hormone antagonist [1-penicillamine,2-leucine]oxytocin in aqueous solutionBiochemistry, 1981
- SYNTHESIS, PHARMACOLOGICAL, CONFORMATIONAL, AND DYNAMIC STUDIES OF THE POTENT HORMONE ANTAGONISTS [1‐PENICILLAMINE, 4‐THREONINE]‐OXYTOCIN AND [1‐PENICILLAMINE, 2‐PHENYLALANINE, 4‐THREONINE] ‐OXYTOCINInternational Journal of Peptide and Protein Research, 1980
- Active site studies of neurohypophyseal hormones. Comparison of oxytocin and arginine vasopressin analogs containing 2-D-tyrosineJournal of the American Chemical Society, 1979
- Carbon-13 NMR studies of the Peptide hormones oxytocin, arginine vasopressin, isotocin, mesotocin, glumitocin, aspartocin, related analogs, and diastereoisomers. Use of specifically deuterated hormone derivatives for assignments and effects of structural changes on carbon-13 NMR chemical shifts in peptidesJournal of the American Chemical Society, 1979
- Synthesis of specifically deuterated S-benzylcysteines and of oxytocin and related diastereomers deuterated in the half-cystine positionsThe Journal of Organic Chemistry, 1976
- Conformation flexibility of the neurohypophyseal hormones oxytocin and lysine-vasopressin. Carbon-13 spin-lattice relaxation study of backbone and side chainsJournal of the American Chemical Society, 1974
- The Preparation of Merrifield‐Resins Through Total Esterification With Cesium SaltsHelvetica Chimica Acta, 1973
- New Agents for t-Butyloxycarbonylation and p-Methoxybenzyloxycarbonylation of Amino AcidsBulletin of the Chemical Society of Japan, 1973
- New machine for automated solid phase peptide synthesisAnalytical Chemistry, 1972
- Synthesis and some pharmacological activities of [2-L-valine]-oxytocin and [2-L-leucine]-oxytocinJournal of Medicinal Chemistry, 1969